YD Bio Limited Ordinary Shares
YDES · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $49,916 | $843,949 | $111,900 | $176,158 |
| - Cash | $3,132 | $87 | $14 | $5 |
| + Debt | $23 | $48 | $0 | $0 |
| Enterprise Value | $46,807 | $843,909 | $111,886 | $176,153 |
| Revenue | $510 | $350 | $0 | $0 |
| % Growth | 45.8% | – | – | – |
| Gross Profit | $155 | $153 | $0 | $0 |
| % Margin | 30.4% | 43.8% | – | – |
| EBITDA | -$1,281 | $22 | $3,790 | $8,704 |
| % Margin | -251% | 6.4% | – | – |
| Net Income | -$1,412 | $14 | $3,788 | $8,704 |
| % Margin | -276.6% | 3.9% | – | – |
| EPS Diluted | -0.56 | 0 | 0.41 | 0.59 |
| % Growth | -280,100% | -100% | -30.5% | – |
| Operating Cash Flow | -$1,837 | -$56 | -$3,023 | -$688 |
| Capital Expenditures | -$2,911 | -$0 | $0 | -$0 |
| Free Cash Flow | -$4,748 | -$56 | -$3,023 | -$688 |